DaVita Healthcare Partners delivers dialysis services to patients with chronic kidney failure and end stage renal disease. The company was founded in 1994 and is based in Denver, Colorado.
DVA Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for DVA, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Davita Inc ranked in the 70th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 225.83% on a DCF basis. The most interesting components of our discounted cash flow analysis for Davita Inc ended up being:
As a business, DVA is generating more cash flow than 85.43% of positive cash flow stocks in the Healthcare.
46% of the company's capital comes from equity, which is greater than only 24.35% of stocks in our cash flow based forecasting set.
Davita Inc's weighted average cost of capital (WACC) is 6%; for context, that number is higher than merely 1.53% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as DVA, try PDEX, NVO, SGRY, ALXN, and LXRX.
Dialysis services provider DaVita ([[DVA]] -3.3%) ended the day in the red, although up 2.4% from the session low of $80.87, on reports that Humana ([[HUM]] +0.5%) has dropped it from its provider network for 2021. ...
DENVER, Sept. 17, 2020 /PRNewswire/ -- DAVITA INC. (NYSE: DVA) ("DaVita") a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today the final…
DaVita (DVA) announces the preliminary results of its modified "Dutch auction" tender offer for up to $1B of its common stock at a price between $77.00 and $88.00, which expired at 12:00 midnight, NYC time, on September 14. A total of 8,000,679 shares were validly tendered and not withdrawn at or below $88.00/share, including 3,388,259 shares...